Nadeen Khoury, MD
Surgery · Jacksonville, FLNPI 1922396548
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $815 of the $1,141 with a category attached, or 71.4%. Novartis accounts for 94.8% of it on its own, with 2 other manufacturers making up the rest. That places this record below the midpoint for surgery clinicians in FL, where the typical reported total is $2,683.
Across 8 payments — averaging $142.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$1K
- Apellis Pharmaceuticals, Inc.$38
- Takeda Pharmaceuticals U.S.A., Inc.$21
Across 4 payments — averaging $30,540 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$122K
What the payments were for
- Travel & lodging$81571%
- Food & beverage$32629%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 6 | $1,082 |
| Apellis Pharmaceuticals, Inc. | 1 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
How this compares
$1,141 in reported general payments places this provider in the 35th percentile of 1,569 surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 23 | $26,280 |
| Envarsus XrTacrolimus | 14 | $10,105 |
| Tacrolimus | 32 | $9,508 |
| Valganciclovir Hcl | 24 | $7,744 |
| Cinacalcet Hcl | 12 | $3,340 |
| Mycophenolate Mofetil | 20 | $2,910 |
| Nifedipine ErNifedipine | 77 | $2,691 |
| Bumetanide | 12 | $1,782 |
| Labetalol Hcl | 19 | $1,412 |
| Calcitriol | 43 | $1,260 |
| Prednisone | 115 | $987 |
| Hydralazine Hcl | 21 | $680 |
| Losartan Potassium | 56 | $579 |
| Carvedilol | 34 | $553 |
| Tamsulosin Hcl | 23 | $551 |
Paid to pharmacies, not to this prescriber.
Other surgery in Jacksonville
- Kenneth JonesJacksonville$267K
- Steven HodgettJacksonville$148K
- Thea PriceJacksonville$115K
- Craig MorgenthalJacksonville$106K
- Jorge FlorinWinter Garden$2.2M
- Amit TaggarTampa$1.4M
- Keith KimCelebration$1.1M
- Richard DiciccoTampa$964K
- Elizabeth DovecLakeland$870K
- Christopher DucoinTampa$808K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.